Your browser doesn't support javascript.
loading
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
Busse, William W; Wenzel, Sally E; Casale, Thomas B; FitzGerald, J Mark; Rice, Megan S; Daizadeh, Nadia; Deniz, Yamo; Patel, Naimish; Harel, Sivan; Rowe, Paul J; Graham, Neil M H; O'Riordan, Thomas; Pavord, Ian D.
Affiliation
  • Busse WW; University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Electronic address: wwb@medicine.wisc.edu.
  • Wenzel SE; Asthma Institute at the University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Casale TB; Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • FitzGerald JM; University of British Columbia, Vancouver, BC, Canada.
  • Rice MS; Sanofi, Cambridge, MA, USA.
  • Daizadeh N; Sanofi, Cambridge, MA, USA.
  • Deniz Y; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Patel N; Sanofi, Bridgewater, NJ, USA.
  • Harel S; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Rowe PJ; Sanofi, Bridgewater, NJ, USA.
  • Graham NMH; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • O'Riordan T; Sanofi, Cambridge, MA, USA.
  • Pavord ID; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Lancet Respir Med ; 9(10): 1165-1173, 2021 10.
Article in En | MEDLINE | ID: mdl-34181876
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Lancet Respir Med Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Lancet Respir Med Year: 2021 Document type: Article Country of publication: